| Recruiting | Investigating Ovulation Inhibition for Use as a Contraceptive Contraception | Phase 2 | 2025-12-22 |
| Recruiting | Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potenti Female Contraception | Phase 3 | 2025-01-13 |
| Completed | Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch Contraception | Phase 2 | 2023-12-22 |
| Completed | Extension Study of MYL-1701P-3001 for Safety and Efficacy Diabetic Macular Edema | Phase 3 | 2020-11-23 |
| Completed | Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macula Diabetic Macular Edema | Phase 3 | 2018-08-23 |
| Completed | MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC NSCLC Stage IV | Phase 3 | 2017-01-21 |
| Completed | A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginiti Atrophic Vaginitis | Phase 3 | 2014-06-01 |
| Completed | A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Tre Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis | Phase 1 | 2013-09-01 |
| Completed | Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion Healthy | Phase 1 | 2013-08-01 |
| Completed | Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg) Healthy | Phase 1 | 2007-10-01 |
| Completed | Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg Healthy | Phase 1 | 2007-07-01 |
| Completed | Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg Healthy | Phase 1 | 2007-07-01 |
| Completed | Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg Healthy | Phase 1 | 2007-06-01 |
| Completed | Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets Healthy | Phase 1 | 2007-05-01 |
| Completed | Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg Healthy | Phase 1 | 2007-04-01 |
| Completed | Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extende Healthy | Phase 1 | 2007-03-01 |
| Completed | Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg Healthy | Phase 1 | 2007-03-01 |
| Completed | Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg Healthy | Phase 1 | 2007-02-01 |
| Completed | Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg Healthy | Phase 1 | 2007-01-01 |
| Completed | Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg Healthy | EARLY_Phase 1 | 2006-12-01 |
| Completed | Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg Healthy | Phase 1 | 2006-12-01 |
| Completed | Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 Healthy | Phase 1 | 2006-11-01 |
| Completed | Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/2 Healthy | Phase 1 | 2006-11-01 |
| Completed | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal Syst Healthy | Phase 1 | 2006-10-01 |
| Terminated | Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Healthy | Phase 1 | 2006-10-01 |
| Completed | Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Healthy | Phase 1 | 2006-08-01 |
| Completed | Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Healthy | Phase 1 | 2006-07-01 |
| Completed | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal Syst Healthy | Phase 1 | 2006-06-01 |
| Completed | Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 m Healthy | Phase 1 | 2006-03-01 |
| Completed | Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg Healthy | Phase 1 | 2006-03-01 |
| Completed | Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg Healthy | Phase 1 | 2006-02-01 |
| Completed | Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg Healthy | Phase 1 | 2006-01-01 |
| Completed | Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg Healthy | Phase 1 | 2006-01-01 |
| Completed | Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 Healthy | Phase 1 | 2006-01-01 |
| Completed | Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Ca Healthy | Phase 1 | 2006-01-01 |
| Completed | Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg Healthy | Phase 1 | 2005-12-01 |
| Completed | Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg Healthy | Phase 1 | 2005-12-01 |
| Completed | Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal Syst Healthy | Phase 1 | 2005-11-01 |
| Completed | Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Healthy | Phase 1 | 2005-11-01 |
| Completed | Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg Healthy | Phase 1 | 2005-10-01 |
| Completed | Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg Healthy | Phase 1 | 2005-10-01 |
| Completed | Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg Healthy | Phase 1 | 2005-10-01 |
| Completed | Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg Healthy | EARLY_Phase 1 | 2005-10-01 |
| Completed | Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg Healthy | Phase 1 | 2005-09-01 |
| Completed | Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg Healthy | Phase 1 | 2005-09-01 |
| Completed | Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg Healthy | Phase 1 | 2005-09-01 |
| Completed | Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg Healthy | Phase 1 | 2005-09-01 |
| Completed | Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg Healthy | Phase 1 | 2005-08-01 |
| Completed | Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg Healthy | Phase 1 | 2005-08-01 |
| Completed | Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg Healthy | Phase 1 | 2005-07-01 |
| Completed | Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg Healthy | Phase 1 | 2005-07-01 |
| Completed | Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg Healthy | Phase 1 | 2005-07-01 |
| Completed | Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg Healthy | Phase 1 | 2005-07-01 |
| Completed | Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg Healthy | Phase 1 | 2005-06-01 |
| Completed | Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg Healthy | Phase 1 | 2005-06-01 |
| Completed | Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg Healthy | Phase 1 | 2005-05-01 |
| Completed | Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg Healthy | Phase 1 | 2005-05-01 |
| Completed | Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg Healthy | Phase 1 | 2005-05-01 |
| Completed | Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg Healthy | Phase 1 | 2005-04-01 |
| Completed | Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg Healthy | Phase 1 | 2005-04-01 |
| Completed | Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg Healthy | Phase 1 | 2005-04-01 |
| Completed | Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg Healthy | Phase 1 | 2005-01-01 |
| Completed | Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg Healthy | Phase 1 | 2004-12-01 |
| Completed | Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg Healthy | Phase 1 | 2004-12-01 |
| Completed | Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Healthy | Phase 1 | 2004-12-01 |
| Completed | Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Healthy | Phase 1 | 2004-12-01 |
| Completed | Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg Healthy | Phase 1 | 2004-12-01 |
| Completed | Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Healthy | Phase 1 | 2004-11-01 |
| Completed | Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Healthy | Phase 1 | 2004-11-01 |
| Completed | Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg Healthy | Phase 1 | 2004-11-01 |
| Completed | Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg Healthy | Phase 1 | 2004-11-01 |
| Completed | Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg Healthy | Phase 1 | 2004-10-01 |
| Completed | Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg Healthy | Phase 1 | 2004-09-01 |
| Completed | Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg Healthy | Phase 1 | 2004-09-01 |
| Completed | Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg Healthy | Phase 1 | 2004-08-01 |
| Completed | Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Healthy | Phase 1 | 2004-07-01 |
| Completed | Comparative Bioavailability Study of Clarithromycin 250 mg Tablets Healthy | Phase 1 | 2004-05-01 |
| Completed | Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg Healhty | Phase 1 | 2004-05-01 |
| Completed | Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg Healthy | Phase 1 | 2004-05-01 |
| Completed | Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg Healthy | Phase 1 | 2004-05-01 |
| Completed | Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg Healthy | Phase 1 | 2004-04-01 |
| Completed | Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg Healthy | Phase 1 | 2004-03-01 |
| Completed | Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg Healthy | Phase 1 | 2004-03-01 |
| Completed | Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg Healthy | Phase 1 | 2004-02-01 |
| Completed | Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg Healthy | Phase 1 | 2004-02-01 |
| Completed | Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg Healthy | Phase 1 | 2004-02-01 |
| Completed | Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg Healthy | Phase 1 | 2004-02-01 |
| Completed | Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg Healthy | Phase 1 | 2004-02-01 |
| Completed | Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg Healthy | Phase 1 | 2003-12-01 |
| Completed | Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg Healthy | Phase 1 | 2003-12-01 |
| Completed | Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg Healthy | Phase 1 | 2003-12-01 |
| Completed | Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg Healthy | Phase 1 | 2003-11-01 |
| Completed | Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg Healthy | Phase 1 | 2003-11-01 |
| Completed | Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg Healthy | Phase 1 | 2003-11-01 |
| Completed | Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State Healthy | Phase 1 | 2003-10-01 |
| Completed | Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg Healthy | Phase 1 | 2003-10-01 |
| Completed | Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg Healthy | Phase 1 | 2003-10-01 |
| Completed | Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg Healthy | Phase 1 | 2003-09-01 |
| Completed | Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg Healthy | Phase 1 | 2003-08-01 |
| Completed | Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg Healthy | Phase 1 | 2003-08-01 |
| Completed | Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Healthy | Phase 1 | 2003-08-01 |
| Completed | Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg Healthy | Phase 1 | 2003-08-01 |
| Completed | Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State Healthy | Phase 1 | 2003-07-01 |
| Completed | Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg Healthy | Phase 1 | 2003-07-01 |
| Completed | Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg Healthy | Phase 1 | 2003-07-01 |
| Completed | Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects Therapeutic Equivalency | Phase 1 | 2003-07-01 |
| Completed | Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg Healthy | Phase 1 | 2003-06-01 |
| Completed | Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg Healthy | Phase 1 | 2003-06-01 |
| Completed | Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Hea Therapeutic Equivalency | Phase 1 | 2003-06-01 |
| Terminated | Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg Healthy | Phase 1 | 2003-05-01 |
| Completed | Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg Healthy | Phase 1 | 2003-05-01 |
| Completed | Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg Healthy | Phase 1 | 2003-05-01 |
| Completed | Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg Healthy | Phase 1 | 2003-05-01 |
| Completed | Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State Healthy | Phase 1 | 2003-03-01 |
| Completed | Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg Healthy | Phase 1 | 2003-03-01 |
| Completed | Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg Healthy | Phase 1 | 2003-02-01 |
| Completed | Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg Healthy | Phase 1 | 2003-01-01 |
| Completed | Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg Healthy | Phase 1 | 2003-01-01 |
| Completed | Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System Healthy | Phase 1 | 2003-01-01 |
| Completed | Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg Healthy | Phase 1 | 2003-01-01 |
| Completed | Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg Healthy | Phase 1 | 2003-01-01 |
| Completed | Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg Healthy | Phase 1 | 2003-01-01 |
| Completed | Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 m Healthy | Phase 1 | 2003-01-01 |
| Completed | Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg Healthy | Phase 1 | 2002-12-01 |
| Completed | Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg Healthy | Phase 1 | 2002-11-01 |
| Completed | Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg Healthy | Phase 1 | 2002-11-01 |
| Completed | Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg Healthy | Phase 1 | 2002-11-01 |
| Completed | Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 Healthy | Phase 1 | 2002-11-01 |
| Completed | Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg Healthy | Phase 1 | 2002-10-01 |
| Completed | Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg Healthy | Phase 1 | 2002-09-01 |
| Completed | Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg Healthy | Phase 1 | 2002-08-01 |
| Completed | Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg Healthy | Phase 1 | 2002-07-01 |
| Completed | Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg) Healthy | Phase 1 | 2002-07-01 |
| Completed | Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg Healthy | Phase 1 | 2002-07-01 |
| Completed | Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg Healthy | Phase 1 | 2002-07-01 |
| Completed | Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg Healthy | Phase 1 | 2002-07-01 |
| Completed | Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg) Healthy | Phase 1 | 2002-06-01 |